THE EFFECT OF MEXIDOL ON GLUTATHIONE SYSTEM IN RAT BRAIN UNDER MODELING OF PARKINSON’S DESEASE
I.M. Mankovska, O.O. Gonchar, L.V. Bratus
O.O. Bogomolets Institute of Physioligy National Academy of
Sciences of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz68.01.013
Abstract
We studied the effects of mexidol (3-oxy-6-methyl-2-ethylpiridine succinate) on the antioxidant glutathione system in
rat brain mitochondria in experimental Parkinson’s disease
induced by rotenone administration. Wistar rats were divided
into the following groups of 6 in each: I - intact rats (control);
II - rotenone (3 mg/kg per day) was injected subcutaneously
for 2 weeks; III - after rotenone intoxication, mexidol (50
mg/kg per day) was injected intraperitoneally for 2 weeks. In
the suspension of brain mitochondria, the activity of NADH
dehydrogenase (complex I of the mitochondrial respiratory
chain), content of the active products of 2-thiobarbituric acid
(TBA-AP), the reduced (GSH) and oxidized (GSSG) glutathione amounts, the activity of glutathione-dependent enzymes:
glutathione peroxidase (GP) and glutathione reductase (GR) as
well as NADH+-isocitrate-dehydrogenase activity (NADPH+-
ICDH) were measured. The activity and protein expression
of MnSOD and GP in rat brain mitochondria were estimated.
Treatment of rats with mexidol led to a weakening of oxidative processes in brain mitochondria in comparison with rats
exposed to rotenone intoxication. It was shown that intraperitoneal injections of mexidol led to a decrease in the TBA-AP and
in the GSSG content and to an increase in GSH/GSSG ratio in comparison with rotenone intoxication. It was also registered
an increase in the activity of NADH-dehydrogenase. Such
changes indicated a weakening of the mitochondrial oxidative
processes intensity. Treatment of rats with mexidol promoted
an increase in GSH content, GR and NADPH+-ICDH activities
in brain mitochondria in comparison with rotenone administration. Treatment with mexidol resulted to an increased activity
and protein expression of GP and MnSOD. We conclude that
mexidol reduced the rotenone-induced damage of rat brain
mitochondria increasing the action of glutathione-dependent
and NADPH+-generating enzymes.
Keywords:
mexidol; rotenone; brain; mitochondria; oxidative processes; glutathione antioxidant system.
References
- Moore D, West A, Dawson V, Dawson T. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci. 2005;28:57-87.
CrossRef
PubMed
- Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909.
CrossRef
- Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev. 1994;74:139-62.
CrossRef
PubMed
- Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000;62:649.
CrossRef
- Gonchar O, Mankovska I, Rozova K, et al. Novel approaches to correction of mitochondrial dysfunction and oxidative disorders in Parkinson's disease. Fiziol Zh. 2019;65(3):61-72. [Ukrainian].
CrossRef
- Voronina TA. Mexidol. The basal effects, mechanisms of action, and use. Moscow. 2005. [Russian].
- Milyuchina IV, Abdurasulova IN, Korzhevsky DE, Klimenko VM. Expression of Parkinson's disease symptoms in rats under various methods of rotenone introduction. Parkinson's disease and movement disorders. Moscow. 2011:380-1 [Russian].
- Gonchar OO, Bratus LV, Karaban IM, Mankovska IM. The effect of Capicor on the protein markers of oxidative stress development in rat brain mitochondria under modeling of Parkinson's disease. Pharm Drug Toxicol. 2020;14(5):316-22. [Ukrainian].
- Raketska OO, Checkman IS, Gorchakova NO. Influence of yakton and mexicor on prooxident- antioxidant homeostasis and synthesis of proteins in rat myocardium under doxorubicine cardiomyopathy. Zaporizh Med J. 2015;2(89):25-7. [Ukrainian].
CrossRef
- Buege J, Aust S. Microsomal lipid peroxidation. Methods Enzymol. 1978;LII:302-8.
CrossRef
- Hatefi Y. Preparation and properties of NADH:Ubiquinine Oxidoreductase (Complex I). Methods Enzymol. 1978;LIII:11-5.
CrossRef
- Anderson M. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 1985;113:548-51.
CrossRef
- Putilina FE. The NADP+-dependent isocitrate dehydrogenase activity determination. Methods Biochem. 1982;1:174-6. [Russian].
Mankovska IM, Gonchar OO, Nosar VI, Rozova KV, Bratus LV, Kolesnikova EE, Putii YuV, Karaban IM. Mitochondrial dysfunction and oxidative lesions in rat brain under modeling of Parkinson's like syndrome: corrective action of Capicor. Fiziol Zh. 2018;64(4):82-
CrossRef
- [Ukrainian].
- Lee S, Koh H, Park D, Song B, Huh T, Park J. Cytosolic NADP+-dependent isocitrate dehyrogenase status modulates oxidative damage to cells. Free Radic Biol Med. 2002;32:1185-96.
CrossRef
- Dickinson D, Forman H. Cellular glutathione and thiols metabolism. Biochem Pharmacol. 2002;64:1019-26.
CrossRef
- Mari M, Morales A, Colell A, Garcia-Ruiz C, FernandezCheca J. Mitochondrial glutathione, a key survival antioxidant. Antiox Redox Sign. 2009;11:2685-700.
CrossRef
PubMed PubMedCentral
- Mankovska IM, Rosova KV, Gonchar OO, Nosar VI, Bratus LV, Drevitska TI, Glazyrin ID, Karasevich NV, Karaban IM. Effect of Capicor on the Parkinson's disease pathogenic links. Fiziol Zh. 2018;64(1):16-24. [Ukrainian].
- Zeevalk G, Razmpour R, Bernard L. Glutathione and Parkinson's disease: Is this the elephant in the room? Biomed Pharmacother. 2008;62:236-49.
CrossRef
PubMed
- Helliwell SB. Development of treatments and therapies to target mitochondrial dysfunction. Mitochondrial dysfunction in neurodegenerative disorders. Springer Int Publ. 2016:349-71.
CrossRef
- Torshin IYU, Gromova OA, Sardaryan IS, Fedotova LE. Comparative chemoreactome analysis of mexidol. J Neurol Psychiatr. 2017;2:75-83. [Russian].
CrossRef
PubMed
- Palee S, Apaijai N, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N. Acetylcholine attenuates hydrogen peroxide-induced intracellular calcium dyshomeostasis through both muscarinic and nicotinic receptors in cardiomyocytes. Cell Physiol Biochem. 2016;39(1):341-9.
CrossRef
PubMed
- Dorszewska J, Florczak J, Rozycka A, JaroszewskaKolecka J, Trzeciak WH, Kozubski W. Polymorphisms of the CHRNA4 gene encoding the alpha 4 subunit of nicotinic acetylcholine receptor as related to the oxidative DNA damage and the level of apoptotic proteins in lymphocytes of the patients with Alzheimer's disease. DNA Cell Biol. 2005;24(12):786-94.
CrossRef
PubMed
- Li Y, King MA, Meyer EM. Alpha 7 nicotinic receptor mediated protection against ethanol induced oxidative stress and cytotoxicity in PC12 cells. Brain Res. 2000; 86(1):165-7.
CrossRef
- Reisman SA, Lee CYI, Meyer CJ, Proksh JW, Ward KW. Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin. Arch Dermatol Res. 2014;306(5):447-54.
CrossRef
PubMed
|